GeneBioTech Co. ,Ltd (KOSDAQ:086060)
South Korea
· Delayed Price · Currency is KRW 5,130.00
-50.00 (-0.97%)
At close: Mar 6, 2026
GeneBioTech Co. ,Ltd Revenue
GeneBioTech Co. ,Ltd had revenue of 24.26B KRW in the quarter ending September 30, 2025, with 18.70% growth. This brings the company's revenue in the last twelve months to 92.28B, up 14.63% year-over-year. In the year 2024, GeneBioTech Co. ,Ltd had annual revenue of 82.96B with 4.38% growth.
Revenue (ttm)
92.28B
Revenue Growth
+14.63%
P/S Ratio
0.47
Revenue / Employee
2.20B
Employees
42
Market Cap
43.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 82.96B | 3.48B | 4.38% |
| Dec 31, 2023 | 79.48B | -3.28B | -3.97% |
| Dec 31, 2022 | 82.76B | 19.94B | 31.75% |
| Dec 31, 2021 | 62.81B | 3.69B | 6.25% |
| Dec 31, 2020 | 59.12B | 874.37M | 1.50% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Korean Drug | 62.21B |
| HLscience | 18.10B |
| Eagle Veterinary Technology Co.,Ltd | 42.51B |
| Kyung Nam Pharm | 56.18B |
| Korea Arlico Pharm | 205.21B |
| RP Bio | 134.21B |
| Jin Yang Pharmaceutical | 117.19B |
| Seoul Pharma | 52.43B |